Stocknear Logo Stocknear
/
Popular
Login

Astellas Pharma Inc.

9.37
0.02 (0.21%)
At close: Apr 21, 2025, 3:57 PM

Astellas Pharma Income Statement

Financials in JPY. Fiscal year is April - March.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017 Mar 31, 2016
1,603.7B 1,518.6B 1,296.2B 1,249.5B 1,300.8B 1,306.3B 1,300.3B 1,311.7B 1,372.7B
292.49B 326.79B 281.29B 269.83B 297.9B 327.26B 330.09B 356.34B 377.98B
1,311.2B 1,191.8B 1,014.9B 979.7B 1,002.9B 979.09B 970.23B 955.33B 994.72B
25.52B 285.43B 220.02B 250.9B 279.42B 280.14B 271.24B 276.42B 270.58B
11.46B 5.21B 794M 683M 2.16B 2.69B 1.65B 978M 985M
24.97B 131.1B 156.4B 144.85B 247.01B 248.97B 218.11B 281.77B 261.77B
17.05B 98.71B 124.09B 120.59B 195.41B 222.26B 164.68B 218.7B 193.69B
740.11B 630.27B 548.84B 504.32B 499.3B 490.26B 478.21B 470.78B 498.48B
294.2B 276.13B 246.01B 224.49B 224.23B 208.68B 220.78B 208.13B 225.66B
251.36B n/a n/a n/a n/a n/a n/a n/a n/a
1,285.7B 906.4B 794.85B 728.8B 723.52B 698.95B 698.99B 678.91B 724.15B
12.01B 3.62B 4.95B 2.33B 3B 1.3B 1.31B 1.33B 1.26B
n/a n/a n/a n/a n/a n/a n/a n/a n/a
1,578.2B 1,233.2B 1,076.1B 998.63B 1,021.4B 1,026.2B 1,029.1B 1,035.2B 1,102.1B
7.92B 33.65B 32.8B 24.73B 49.94B 26.7B 53.43B 63.07B 68.08B
1.79B 1.82B 1.85B 1.86B 1.88B 1.93B 2.03B 2.11B 2.16B
1.8B 1.83B 1.85B 1.86B 1.88B 1.93B 2.03B 2.11B 2.16B
9.51 54.24 67.08 64.93 104.15 115.05 81.11 103.69 89.75
9.47 54.09 67.05 64.90 104.08 114.94 81.02 103.55 89.62
194.81B 246.88B 241.52B 220.31B 314.75B 313.73B 284.76B 347.54B 332.58B
36.97B 141.14B 161.84B 147.66B 248.35B 250.27B 219.9B 283.75B 263.4B
157.84B 105.74B 79.68B 72.65B 66.4B 63.46B 64.86B 63.79B 69.19B

Create Price Alert on ALPMY

Your price alert will notify you when the stock price is above 9.37.

Add to Watchlist